Cargando…

SARS-CoV-2 vaccines–induced thrombotic thrombocytopenia: should we consider immuno-hypersensitivity?

The coronavirus disease 2019 (COVID-19) pandemic is significantly causing unprecedented clinical, socioeconomic, and public health challenges globally. The successful global administration of effective, safe and sustainable vaccine(s) is widely believed to be crucial in mitigating as well as prevent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reuben, Rine Christopher, Adogo, Lillian Yami
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Faculdade de Saúde Pública da Universidade de São Paulo 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522756/ https://www.ncbi.nlm.nih.gov/pubmed/34730750 http://dx.doi.org/10.11606/s1518-8787.2021055003855

Ejemplares similares

Probiotics potentials in mitigating coronavirus disease (COVID-19) pandemic
por: Reuben, Rine Christopher, et al.
Publicado: (2021)

Lessons from vaccine-induced immune thrombotic thrombocytopenia
por: Kelton, John Greenhow, et al.
Publicado: (2021)

Most cases of Thrombosis and Thrombocytopenia Syndrome (TTS) post ChAdOx-1 nCov-19 are Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT)
por: Makris, Michael, et al.
Publicado: (2021)

COVID-19 vaccine: what are we doing and what should we do?
por: Candelli, Marcello
Publicado: (2022)

Developing health policies in patients presenting with SARS-CoV-2: consider tuberculosis
por: Keddy, Karen H, et al.
Publicado: (2020)

Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy
por: Jensen, Jeffrey D., et al.
Publicado: (2020)

Should we splint traumatised primary teeth?
por: Deery, Chris
Publicado: (2023)

Active surveillance should be considered for select men with Grade Group 2 prostate cancer
por: Pekala, Kelly R., et al.
Publicado: (2023)

Active surveillance should not be routinely considered in ISUP grade group 2 prostate cancer
por: Gandaglia, Giorgio, et al.
Publicado: (2023)

SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
por: Cines, Douglas B., et al.
Publicado: (2021)

SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia
por: Liu, Yumei, et al.
Publicado: (2022)

ECMO for severe ARDS associated with COVID-19: now we know we can, but should we?
por: Shekar, Kiran, et al.
Publicado: (2020)

The upcoming flu seasons: how worried should we be?
por: Kayali, Ghazi
Publicado: (2022)

Azd-1222: Hypersensitivity and immune thrombotic thrombocytopenia: 2 case reports
Publicado: (2021)

Understanding risk of thrombosis with thrombocytopenia syndrome after Ad26.COV2.S vaccination
por: Kulkarni, Prathit A., et al.
Publicado: (2021)

Should we worry about the accumulation of microplastics in human organs?
por: Sorci, Gabriele, et al.
Publicado: (2022)

Revisiting the diagnosis of ‘resistant hypertension’: what should we do nowadays’
por: Alsharari, Reem, et al.
Publicado: (2021)

Should we ration extracorporeal membrane oxygenation during the COVID-19 pandemic?
por: Supady, Alexander, et al.
Publicado: (2021)

SARS-CoV-2 vaccination and phase 1 cancer clinical trials
por: Yap, Timothy A, et al.
Publicado: (2021)

Genomic testing for rare disease diagnosis—where are we now, and where should we be heading? The reflections of a behavioural scientist
por: Lewis, Celine
Publicado: (2023)

Open questions: why should we care about ER-phagy and ER remodelling?
por: Dikic, Ivan
Publicado: (2018)

Cutaneous skin manifestation following messenger RNA Moderna SARS-CoV-2 vaccine with dermal hypersensitivity reaction histopathology
por: Chopra, Shara, et al.
Publicado: (2021)

Vaccine‐induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources
por: Greinacher, Andreas, et al.
Publicado: (2022)

The use of single-cell multi-omics in immuno-oncology
por: Ma, Anjun, et al.
Publicado: (2022)

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination
por: Muir, Kate-Lynn, et al.
Publicado: (2021)

SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban
por: Guetl, Katharina, et al.
Publicado: (2021)

Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know
por: Arepally, Gowthami M., et al.
Publicado: (2021)

Vaccine-induced immune thrombotic thrombocytopenia: what do we know hitherto?
por: Roytenberg, Renat, et al.
Publicado: (2023)

Thrombocytopenia in COVID-19 and vaccine-induced thrombotic thrombocytopenia
por: Geronikolou, Styliani A., et al.
Publicado: (2022)

Should We Be Ablating the Kidneys or the Heart to Prevent Arrhythmias?
por: Wilson, Lance D., et al.
Publicado: (2017)

How should we interpret estimates of individual repeatability?
por: Wilson, Alastair J.
Publicado: (2018)

Renal denervation revisited; should we pay attention?
por: de Winter, R. J.
Publicado: (2022)

SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: Elalamy, Ismail, et al.
Publicado: (2021)

Trichloroethylene Hypersensitivity Syndrome: Should Be Considered When Diagnosing DRESS Syndrome
por: Kang, Young Joong, et al.
Publicado: (2018)

Bell's palsy and SARS-CoV-2 vaccines
por: Ozonoff, Al, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in people with HIV
por: Spinelli, Matthew A
Publicado: (2021)

Optimising SARS-CoV-2 vaccination schedules
por: Belda-Iniesta, Cristobal
Publicado: (2021)

Vaccine-induced immune thrombotic thrombocytopenia
por: Klok, Frederikus A, et al.
Publicado: (2022)

Perspectives on vaccine induced thrombotic thrombocytopenia
por: Dotan, Arad, et al.
Publicado: (2021)

Vaccine-induced immune thrombotic thrombocytopenia
por: Kanack, Adam J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pfl6jqbjb03ujmmtgho3pkrp38